| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 569 | 3.593 | 3.602 | 11.898 | 20.420 | 29.122 | 33.251 |
| Total Income - EUR | - | - | - | 569 | 3.593 | 3.603 | 11.908 | 20.420 | 29.122 | 33.251 |
| Total Expenses - EUR | - | - | - | 64 | 498 | 1.244 | 3.441 | 6.338 | 15.660 | 17.063 |
| Gross Profit/Loss - EUR | - | - | - | 504 | 3.094 | 2.359 | 8.466 | 14.082 | 13.462 | 16.188 |
| Net Profit/Loss - EUR | - | - | - | 487 | 2.986 | 2.251 | 8.109 | 13.692 | 13.171 | 15.190 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Florescu Dan Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 547 | 3.526 | 2.432 | 8.654 | 27.074 | 15.312 | 19.329 |
| Inventories | - | - | - | 0 | 6 | 6 | 6 | 6 | 6 | 6 |
| Receivables | - | - | - | 150 | 0 | 870 | 729 | 13.040 | 2.266 | 15.192 |
| Cash | - | - | - | 397 | 3.520 | 1.556 | 7.919 | 14.027 | 13.040 | 4.132 |
| Shareholders Funds | - | - | - | 530 | 3.506 | 2.301 | 8.158 | 13.741 | 13.219 | 15.239 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 17 | 20 | 131 | 496 | 13.332 | 2.093 | 4.091 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Florescu Dan Med S.r.l.